Detalhe da pesquisa
1.
A novel computer-assisted tool for 3D imaging of programmed death-ligand 1 expression in immunofluorescence-stained and optically cleared breast cancer specimens.
BMC Cancer
; 24(1): 121, 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267903
2.
Factors associated with survival of patients with advanced lung cancer and long travel distances.
J Formos Med Assoc
; 123(2): 273-282, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633771
3.
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours.
Br J Cancer
; 122(9): 1324-1332, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32161368
4.
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib.
Oncologist
; 25(8): 702-711, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32386255
5.
A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors.
Invest New Drugs
; 38(1): 99-110, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30825104
6.
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations.
Int J Cancer
; 144(11): 2887-2896, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30485437
7.
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors.
Oncologist
; 24(12): e1417-e1425, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31127020
8.
Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors.
Am J Respir Crit Care Med
; 195(5): 663-673, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27669169
9.
Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors.
J Formos Med Assoc
; 117(4): 326-331, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28499641
10.
Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors.
J Biomed Sci
; 23(1): 86, 2016 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27912760
11.
Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells.
Proc Natl Acad Sci U S A
; 109(52): E3659-67, 2012 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23236152
12.
Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors.
Proc Natl Acad Sci U S A
; 107(29): 13040-5, 2010 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20615970
13.
Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly according to specialty: an international survey of clinical practice.
J Thorac Dis
; 15(8): 4367-4378, 2023 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37691657
14.
Potential Therapeutic Strategy for EGFR-Mutant Lung Cancer With Concomitant EML4-ALK Rearrangement-Combination of EGFR Tyrosine Kinase Inhibitors and ALK Inhibitors.
JTO Clin Res Rep
; 3(11): 100405, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36325153
15.
The impact of BRAF targeting agents in advanced anaplastic thyroid cancer: a multi-institutional retrospective study in Taiwan.
Am J Cancer Res
; 12(11): 5342-5350, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36504909
16.
Recommended first-line management of brain metastases from melanoma: A multicenter survey of clinical practice.
Radiother Oncol
; 168: 89-94, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121033
17.
Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma.
Ther Adv Med Oncol
; 14: 17588359221133889, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36324732
18.
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M-Positive NSCLC.
JTO Clin Res Rep
; 2(1): 100099, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34589970
19.
Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer.
J Formos Med Assoc
; 109(5): 338-44, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20497866
20.
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors.
Eur J Cancer
; 124: 110-122, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31760310